Independent equity research
Company analysis, SEC filing changes and public follow-ups. Read the thesis, inspect the assumptions, and see what happened next.
Free research to read now. Premium research is coming.
New to LF0?
Understand a thesis. Audit a call. Compare a filing.
01 / Read a stock thesis
FormFactor (FORM) is rated Hold as AI and HBM demand are driving strong growth, but the stock already discounts much of the upside. Rich valuation and customer concentration keep the…
Read the research02 / Check the follow-up
Revisiting our Sell call on TTWO: entry $247.62, latest $201.28, -18.7%.
Read the research03 / See what changed
Naploy (NPLY) 2026 10-K analysis comparing the 30 October 2026 filing with its prior-year 10-K, highlighting the MD&A section's biggest changes.
Read the researchFrom the research desk
Enphase Energy (ENPH) carries a STRONG SELL rating as shrinking revenue and a still-rich valuation outweigh its strong cash balance. The business has a solid platform, but the top line…
Read the researchWilliams Companies (WMB) is rated Hold because its fee-based pipeline franchise is durable, but the stock already trades at a rich multiple. Negative free cash flow and 4.35x net debt/EBITDA…
Read the researchSM Energy (SM) is a Buy, backed by $1.5B in trailing free cash flow and a 15.5% FCF yield. The stock looks undervalued at 5.1x EV/EBITDA, but leverage and tight…
Read the researchNaploy (NPLY) 2026 10-K analysis comparing the 30 October 2026 filing with its prior-year 10-K, highlighting the MD&A section's biggest changes.
Read the researchRafael Holdings (RFL)'s MD&A section changed the most among 6 companies that filed 10-Ks on 29 October 2026, each compared against its prior-year filing.
Read the researchZedge (ZDGE)'s Business section changed the most among 5 companies that filed 10-Ks on 28 October 2026, each compared against its prior-year filing.
Read the researchRevisiting our Sell call on TTWO: entry $247.62, latest $201.28, -18.7%.
Read the researchRevisiting our Sell call on NXE: entry $10.40, latest $8.80, -15.4%.
Read the researchRevisiting our Sell call on DOCN: entry $136.29, latest $106.39, -21.9%.
Read the researchLF0 Research Desk
A rating is a thesis to examine. The original analysis and later scorecard reviews let you see both the reasoning and the outcome.
Stay connected
The current research is free to browse. The waitlist is for news about deeper premium analysis when it launches.
This form joins the LF0 premium waitlist. Substack is a separate subscription. You can read the current research without joining either.
Follow your interests
Explore more of the company analyses featured on LF0.